DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000HC9Z2F2

Real-time BOERSE MUENCHEN 11:46:24 2024-07-04 EDT
0.21 EUR -4.55% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
1 month+22.22%
3 months-60.71%
Date Price Change
24-07-04 0.21 -4.55%
24-07-03 0.22 -4.35%
24-07-02 0.23 +4.55%
24-07-01 0.22 0.00%
24-06-28 0.22 -4.35%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 11:46 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC9Z2F
ISINDE000HC9Z2F2
Date issued 2023-10-17
Strike 30
Maturity 2024-09-18 (76 Days)
Parity 1 : 1
Emission price 0.76
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.15
Spread 0.04
Spread %17.39%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.61 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.25%
Consensus